Pre-Filled Saline Syringes Market to Grow at a CAGR of 7.2% to reach US$ 744.4 Mn from 2018 to 2027

Pre-Filled Saline Syringes Market to 2027 - Global Analysis and Forecasts by Type (3ml Syringes, 5ml Syringes, 10ml Syringes, and Others); End User (Hospitals, Outpatient Clinics, and Homecare Settings), and Country

Publication Month : Jun 2019

  • Report Code : TIPRE00005460
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 153
Inquire Before Buy

PRICING

$4550

$2730

The Pre-Filled Saline Syringes market was valued at US$ 402.5 million in 2018 and it is projected to reach US$ 744.4million by 2027; it is expected to grow at a CAGR of 7.2% from 2019 to 2027.

Pre-filled saline syringes are single-dose packet of saline to which a needle has been fixed by the manufacturer. These are medical consumables that are used in hospitals and clinics for clearing intravenous lines (IVs), any medicine or perishable liquids used to keep the arterial lines and entry point clean and sterile. The growth of the Pre-Filled Saline Syringes market is attributed to the increased medication errors, risk of cross-contamination in multi-dose vials, increase in home care and self-injectable medicines to avoid visits to hospitals, and increasing incidence of hospital-acquired infections are key drivers for the growth of the market. However, factors such as stringent regulatory criteria for approval pre-filled saline syringes are likely to restrain the market growth to a certain extent.

The Pre-Filled Saline Syringes market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Pre-Filled Saline Syringes market



Lucrative Regions for Pre-Filled Saline Syringes in Healthcare Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Growing Applications of Pre-Filled Saline Syringes in Healthcare to Drive Pre-Filled Saline Syringes market Growth

Pre-filled saline syringes are widely used in hospitals, nursing homes, and some types of pre-filled saline syringes can be used at home too. Pre-filled saline syringes are used to clean out an intravenous (IV) catheter, to prevent blockage and remove any medicine left in the catheter area after an IV infusion. Thus rising prevalence of chronic diseases like CVD, cancer, diabetes, and others drives the market growth of pre-filled saline syringes.

Also, according to the World Health Organization in 2018, cancer was the second leading cause of death across the globe and is responsible for an estimated 9.6 million deaths in 2018. Furthermore, the American Cancer Society estimated that in 2018, 1,735,350 new cancer cases were diagnosed in 2018. 

Diabetes is one of the most significant global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications. According to the International Diabetes Federation (IDF), in 2017, the number of people with diabetes in North America was approximately 46 million, which is expected to grow at 62 million in 2045. The increase in disease prevalence is around 35% during the forecast period.

Thus, the increasing incidences of chronic diseases pose several opportunities for the pre-filled saline syringes market to grow during the forecast period.

Hospital-acquired infections affect the patients not only during their stay in the hospitals but also post patient’s discharge from hospitals. Pre-filled saline syringes are designed to reduce hospital-acquired infections, reduce the risk of medication errors, and lower the risk of catheter damage. Moreover, these occupational infections are observed to be common within the hospital and nursing staff too. According to the World Health Organization (WHO), hundreds of millions of patients are affected by healthcare-associated infections every year, leading to significant morbidity and mortality around the world. The WHO Healthcare Associated Infections fact sheet of 2016 suggests that of every 100 hospitalized patients at a given time, seven patients in the developed countries and ten patients in developing countries get the hospital-acquired infection.

Moreover, in high-income countries, approximately 30% of patients in intensive care units (ICUs) are affected by at least one HAIs. This rate of HAIs is about 2-3 folds higher in the low and middle-income countries. Besides, the WHO claims that the newborns are at a higher risk of developing these infections, with infection rates 3-20 times higher in developing countries as compared to high-income countries of the globe. As a result of this significant prevalence rate of these infections, the endemic burden of healthcare-associated infections is also turning up higher, majorly among the developing economies of the world. The European Centre for Disease Prevention and Control reports an average prevalence of 7.1% in European countries. 

The Centre estimates that 4,131,000 patients are affected by approximately 4,544,100 episodes of healthcareassociated infection every year in Europe. Thus, the increasing prevalence of HAIs is expected to create a demand for disposable medical products such as pre-filled saline syringes, promoting market growth across the world.. Introduction of various rules and regulations in the past few years have led to implementing better facilities, inventories, and efficient practices to offer improved and better procedure and several healthcare services. For instance, in 2006, the U.S. implemented the Health Act, which makes it mandatory for health care institutions to implement certain practices to prevent and control infections associated with treatments, increasing medication errors, risk of cross-contamination in multi-dose vials. 

Furthermore, laws encouraging the prevention and reduction of healthcare-associated infections (HAIs), infections acquired during the course of receiving treatment for other health conditions, cross-contamination of medication, have emerged and expanded in states. The Patient Protection and Affordable Care Act (PPACA) of 2010 has specific patient protection provisions aimed at reducing HAIs throughout acute-care hospitals. The new law has financial penalties for hospitals with the highest rates of HAIs. Medicaid is prohibiting payments to hospitals for specific HAIs. Second, the new law requires mandatory public reporting of HAI rates for all hospitals. This has made the usage of pre-filled saline syringes and other health care related equipment imperative in medical practices. These regulations further ensure increased emphasis on measures to control infections, thereby directly promoting the use of pre-filled saline syringes to negate the chances of any form of infection.

Medical supplies are widely used for the geriatric population as it assists the healthcare professionals to administer medication/ hormone/ nutrition and others. For instance, cancer is a major cause of morbidity and mortality in aging population that later primarily attributable to various chronic complications. The number of aging people with cancer is increasing due to increased lifespan and the increased prevalence of cancer in the geriatric population worldwide. Prefilled saline syringes are a regular requirement for cancer patients provides more flexibility while giving them greater control of the disease.

The elderly population is defined as a group of people aged 65 and over. Population aging is poised to become one of the most significant social transformations of the twenty-first century. According to the report of the United Nations, in 2017, there were approximately 962 million people aged 60 or over across the globe, that consists of 13% of the global population. The population aged 60 or above is growing at a rate of about 3 percent per year. Across the globe, the number of persons aged 80 or above is projected to triple by 2050. The approximate population is around 137 million in 2017, which will reach up to 425 million in 2050. The value is expected to increase to 909 million in 2100, around seven times its value in 2017. The elderly people are more likely to have cancer than younger people, and the effect of the disease on quality of life is particularly deep in this population. With an increase in the number of geriatric population, the prevalence of chronic diseases has increased. Therefore, the demand for pre-filled saline syringes products are expected to increase in the forecast period.

Type -Based Insights

In terms of type, the Pre-Filled Saline Syringes market is segmented into 3ml syringes, 5ml syringes, 10ml syringes, and others. In 2018, the 3 ml syringes segment held a largest market share of 46.4% of the pre-filled saline syringes market, by type.

Pre-Filled Saline Syringes market, by Type – 2018 and 2027



Pre-Filled Saline Syringes in Healthcare Market, by Type – 2018 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

End User-Based Insights

In terms of end user, the Pre-Filled Saline Syringes market is segmented into hospitals, outpatient clinics, and homecare settings. In 2017, the hospitals segment is accounted for the largest share. This is primarily attributed to the high demand for 3 ml syringes in hospitals and growing number of multispecialty hospitals.


Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Pre-Filled Saline Syringes Market: Strategic Insights

pre-filled-saline-syringes-market
Market Size Value inUS$ 402.5 Million in 2018
Market Size Value byUS$ 744.4Million by 2027
Growth rateCAGR of 7.2% from 2019-2027
Forecast Period2019-2027
Base Year2019
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The Pre-Filled Saline Syringes market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Pre-Filled Saline Syringes market – by Type

  • 3ml Syringes
  • 5ml Syringes
  • 10ml Syringes
  • Others

Pre-Filled Saline Syringes market – by End User

  • Hospitals
  • Outpatient Clinics
  • Homecare Settings

Pre-Filled Saline Syringes market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • BD
  • Cardinal Health
  • MedXL Inc.
  • Guerbet Group
  • Sterisets Medical Products
  • DBM
  • B. Braun Medical Inc.
  • Wolf Medical Inc.
  • Aquabiliti
  • Baxter Healthcare Corporation
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type ; End User , and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

The List of Companies

  1. BD
  2. Cardinal Health
  3. MedXL Inc.
  4. Guerbet Group
  5. Sterisets Medical Products
  6. DBM
  7. B. Braun Medical Inc.
  8. Wolf Medical Inc.
  9. Aquabiliti
  10. Baxter Healthcare Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pre-Filled Saline Syringes Market